Skip to main content
MEHA
OTC Life Sciences

Functional Brands Reports $9.6M Loss, Defaults on Series C and Notes, Going Concern Doubt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
9
Price
$0.005
Mkt Cap
$206.812K
52W Low
$0.004
52W High
$8
52W Position info
22% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

MEHA sits 22% above its 52-week low of $0.004.

Summary

Functional Brands Inc. reported a $9.6 million net loss for H1 2026, disclosed going concern doubt, and is in default on its Series C Preferred and Senior Secured Convertible Notes after missing a mandatory redemption and losing its Nasdaq listing.


Key Events · Earnings and Guidance · MEHA

  • Going Concern Doubt

    Cash of $352,142, working capital deficit of $2,903,380, and accumulated deficit of $16,679,712 raise substantial doubt about the company's ability to continue as a going concern.

  • Defaults on Series C and Notes

    Failure to commence mandatory redemption on June 8, 2026, and Nasdaq delisting on June 16, 2026, constitute events of default under the Series C Preferred and Senior Secured Convertible Notes.

  • Default Penalties

    Dividend rate on Series C increased to 24%, Notes obligations increased to 125%, default interest rate of 24%, monthly monitoring fee of $5,000, and conversion price reduced to 85% of lowest trading price.

  • Massive Net Loss

    Net loss of $9,621,337 for the six months ended June 30, 2026, driven by a $6,310,464 loss on preferred stock issuance and a $942,568 change in fair value of derivative liabilities.


Analysis · MEHA · Life Sciences

The 10-Q reveals the company is in default on its Series C Preferred and Senior Secured Convertible Notes due to missed mandatory redemption and Nasdaq delisting. Cash has dwindled to $352,142 against a working capital deficit of $2.9 million, raising substantial doubt about its ability to continue as a going concern. The defaults trigger a 24% dividend rate, a 125% obligation increase on the Notes, and a conversion price cut to 85% of the lowest trading price, which could lead to massive dilution if holders convert. The company also recognized a $6.3 million loss on preferred stock issuance and a $942,568 derivative loss, driving a net loss of $9.6 million for the first half of 2026.

At the time of this filing, MEHA was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $206.8K. The 52-week trading range was $0.00 to $8.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
MEHA
Jun 05, 2026, 2:29 PM EDT
Source: TMX Newsfile
Importance Score:
7